By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich announced last night that it has priced an aggregate principal amount of $300 million of senior notes due 2020 through a public offering.

The St. Louis-based research products and chemicals firm said that it would use proceeds from the offering for general corporate purposes.

The notes have a 10-year maturity, an issue price of 99.915 percent, and a fixed rate coupon of 3.375 percent, payable semi-annually.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.